Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

When the company reported VK2735's phase 2 results last year, the stock jumped 121% in one trading session. Viking gave back ...

Key Takeaways AbbVie's fourth-quarter revenue exceeded forecasts on higher sales of its Skyrizi and Rinvoq drugs to treat ...

Evaxion Biotech (EVAX) shares fell over 25% premarket on Thursday after the company priced an offering to raise $10.8M. The ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) stock is up 6% at $465.02 at last glance, after the U.S. Food and Drug ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...